T-O (am): N/A (08:59:00)
Last updated: 17:00
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|
| EPS | 5.1 sen |
| Trailing PE (Sector Median: 22.5) | 14.7 |
| PEG | 0 |
| Altman Z | 0.0 |
| Beaver | 0 |
| Current Ratio | 0 |
| Debt-Equity (DE) Ratio | 0 |
| FCF Yield | 0.0 % |
| Revenue QoQ | 0 % |
| Revenue YoY | N/A |
| Profit QoQ | 0 % |
| Profit YoY | 0 % |
| Profit Margin (Sector Median: 2.6) | 11.1 % |
| ROE (ROIC: 0) | 0 % |
| Dividend Per Share (DPS) | 0 sen |
| Dividend Yield (DY) | 0.0 % |
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 22.5) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 2.6) | |
| ROE | |
| Altman Z |
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 3 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 11.1 | Consistent QR FV |
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
No transaction in the last 2 months.
Market Cap: 300 M.
Market Cap Class: Small caps
Number of Shares: 400 M.
Adjusted Float: 0%.
LAC Med Berhad, through its subsidiaries, specialises in the supply and integration of medical devices in Malaysia and Indonesia. The Group is an authorised distributor for third-party brands of medical devices, including medical equipment primarily used for diagnostic purposes, and associated products like medical consumables. It also provides software and system integration services. A key part of its business involves the provision of ICT products and services tailored for healthcare facilities. The company was incorporated in Malaysia in November 2024 and has since expanded its operations regionally with the establishment of PT Fairmed in Indonesia.
Sectors: Health Care, Health Care Equipment & Services
Code: 5341
Website: www.lacmed.com
Related Links: Bursa | Annual Report | Announcement
No warrants listed
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham Pro(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |